The Pennant Group, Inc. (PNTG)
USD 28.15
(-3.63%)
USD 28.15
(-3.63%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 13.37 Million USD | 101.4% |
| 2022 | 6.64 Million USD | 209.26% |
| 2021 | 2.14 Million USD | -86.36% |
| 2020 | 15.74 Million USD | 518.38% |
| 2019 | 2.54 Million USD | -83.77% |
| 2018 | 15.68 Million USD | 58.95% |
| 2017 | 9.86 Million USD | 25.04% |
| 2016 | 7.89 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 5.69 Million USD | 15.98% |
| 2024 Q1 | 4.9 Million USD | 12.81% |
| 2023 Q1 | 1.85 Million USD | -46.75% |
| 2023 FY | 13.37 Million USD | 101.4% |
| 2023 Q2 | 2.79 Million USD | 51.19% |
| 2023 Q3 | 4.38 Million USD | 56.7% |
| 2023 Q4 | 4.34 Million USD | -0.78% |
| 2022 Q4 | 3.47 Million USD | -28.09% |
| 2022 FY | 6.64 Million USD | 209.26% |
| 2022 Q3 | 4.83 Million USD | 286.09% |
| 2022 Q2 | -2.59 Million USD | -356.02% |
| 2022 Q1 | 1.01 Million USD | 147.18% |
| 2021 Q2 | 2.65 Million USD | 178.95% |
| 2021 Q1 | 950 Thousand USD | -76.37% |
| 2021 FY | 2.14 Million USD | -86.36% |
| 2021 Q3 | 1.24 Million USD | -53.02% |
| 2021 Q4 | -2.14 Million USD | -272.61% |
| 2020 Q2 | 4.33 Million USD | 45.54% |
| 2020 FY | 15.74 Million USD | 518.38% |
| 2020 Q4 | 4.02 Million USD | -8.78% |
| 2020 Q3 | 4.4 Million USD | 1.61% |
| 2020 Q1 | 2.98 Million USD | 178.44% |
| 2019 Q2 | 3.48 Million USD | 161.39% |
| 2019 FY | 2.54 Million USD | -83.77% |
| 2019 Q3 | 1.52 Million USD | -56.29% |
| 2019 Q1 | 1.33 Million USD | -64.62% |
| 2019 Q4 | -3.79 Million USD | -349.28% |
| 2018 Q2 | 4.16 Million USD | 23.07% |
| 2018 Q3 | 4.37 Million USD | 5.07% |
| 2018 FY | 15.68 Million USD | 58.95% |
| 2018 Q1 | 3.38 Million USD | 0.0% |
| 2018 Q4 | 3.77 Million USD | -13.77% |
| 2017 FY | 9.86 Million USD | 25.04% |
| 2016 FY | 7.89 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | -21.66 Million USD | 161.748% |
| Addus HomeCare Corporation | 62.51 Million USD | 78.599% |
| AirSculpt Technologies, Inc. | -4.47 Million USD | 398.705% |
| Amedisys, Inc. | -9.74 Million USD | 237.263% |
| American Oncology Network, Inc. | -5.54 Million USD | 341.411% |
| Astrana Health, Inc. | 60.71 Million USD | 77.965% |
| Aveanna Healthcare Holdings Inc. | -134.52 Million USD | 109.945% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 3.31 Million USD | -303.468% |
| Cryo-Cell International, Inc. | -9.52 Million USD | 240.511% |
| Cross Country Healthcare, Inc. | 72.63 Million USD | 81.579% |
| COMPASS Pathways plc | -118.46 Million USD | 111.294% |
| DocGo Inc. | 6.85 Million USD | -95.073% |
| The Ensign Group, Inc. | 209.39 Million USD | 93.611% |
| Healthcare Services Group, Inc. | 38.38 Million USD | 65.146% |
| InnovAge Holding Corp. | -21.33 Million USD | 162.7% |
| Assure Holdings Corp. | -26.07 Million USD | 151.304% |
| The Joint Corp. | -9.75 Million USD | 237.19% |
| LifeStance Health Group, Inc. | -186.26 Million USD | 107.183% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.6 Million USD | 185.747% |
| ModivCare Inc. | -204.46 Million USD | 106.544% |
| NewGenIvf Group Limited | 130.19 Thousand USD | -10176.282% |
| Novo Integrated Sciences, Inc. | -13.21 Million USD | 201.244% |
| Option Care Health, Inc. | 267.09 Million USD | 94.991% |
| P3 Health Partners Inc. | -57.77 Million USD | 123.158% |
| P3 Health Partners Inc. | -57.77 Million USD | 123.158% |
| Surgery Partners, Inc. | -11.9 Million USD | 212.429% |
| Syra Health Corp. Class A Common Stock | -2.93 Million USD | 555.325% |
| Talkspace, Inc. | -19.18 Million USD | 169.748% |
| Talkspace, Inc. | -19.18 Million USD | 169.748% |
| The Oncology Institute, Inc. | -83.06 Million USD | 116.106% |
| The Oncology Institute, Inc. | -83.06 Million USD | 116.106% |